Fran DeGrazio

Jun 20, 2024 | pharmaceuticalonline.com | Jason O. Boyd |Fran DeGrazio |Seahee Kim

Webinar: Enhancing Facility Operations with Digital Twin TechnologyJoin us for an insightful webinar on June 28th where we explore the transformative power of Digital Twin technology in modern facility management. Through real-world examples and expert insights, you'll learn how virtual replicas of physical facilities can revolutionize operations, maintenance, and strategic planning across various industries.

Jun 6, 2024 | drugdeliveryleader.com | Fran DeGrazio

Source: Kymanox Corporation By Fran DeGrazio, Executive Advisor, Kymanox Corporation Materials used in a drug package or device design are fundamental to ensuring a safe and effective drug development program. The recent growth in complex therapeutics has increased demand for sophisticated packaging and device designs as these products are extremely sensitive to their environmental and storage conditions.

Jun 2, 2024 | pharmaceuticalonline.com | Fran DeGrazio

By Fran DeGrazio, Executive Advisor, Kymanox Corporation Materials used in a drug package or device design are fundamental to ensuring a safe and effective drug development program. The recent growth in complex therapeutics has increased demand for sophisticated packaging and device designs as these products are extremely sensitive to their environmental and storage conditions.

Oct 6, 2023 | pharmaceuticalonline.com | Fran DeGrazio |Brian Svaton |Nikka Densok USA |Josh Russell

The FDA now defines a prefilled syringe, a product that was at one point considered “packaging” for a drug, as a constituent part of a combination product. The ultimate combination of the drug, its package, and its delivery device means that during development and manufacturing you need to combine both drug and device current good manufacturing practices (cGMPs) and quality approaches.

Sep 21, 2023 | biosimilardevelopment.com | Fran DeGrazio |Aditi Shivarkar |Victoria Meyer

Get more biosimilar development insight with our FREE newsletter Newsletter | September 21, 2023 The FDA now defines a prefilled syringe, a product that was at one point considered “packaging” for a drug, as a constituent part of a combination product.